3,667 Shares in CVS Health Co. (NYSE:CVS) Purchased by WoodTrust Financial Corp

WoodTrust Financial Corp acquired a new position in shares of CVS Health Co. (NYSE:CVS) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,667 shares of the pharmacy operator’s stock, valued at approximately $231,000.

Several other institutional investors have also added to or reduced their stakes in the company. Norden Group LLC grew its position in CVS Health by 10.7% during the first quarter. Norden Group LLC now owns 6,830 shares of the pharmacy operator’s stock worth $545,000 after buying an additional 660 shares in the last quarter. GSA Capital Partners LLP bought a new position in shares of CVS Health in the first quarter worth $536,000. Advisory Alpha LLC raised its stake in CVS Health by 9.6% in the first quarter. Advisory Alpha LLC now owns 3,753 shares of the pharmacy operator’s stock valued at $299,000 after purchasing an additional 329 shares in the last quarter. Manchester Capital Management LLC grew its stake in CVS Health by 131.5% during the first quarter. Manchester Capital Management LLC now owns 5,281 shares of the pharmacy operator’s stock worth $421,000 after buying an additional 3,000 shares in the last quarter. Finally, Empirical Finance LLC increased its holdings in CVS Health by 3.4% in the 1st quarter. Empirical Finance LLC now owns 46,735 shares of the pharmacy operator’s stock valued at $3,728,000 after buying an additional 1,535 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 11.3 %

NYSE:CVS opened at $61.61 on Thursday. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The firm has a fifty day simple moving average of $59.59 and a two-hundred day simple moving average of $59.23. The stock has a market capitalization of $77.50 billion, a price-to-earnings ratio of 10.96, a PEG ratio of 0.82 and a beta of 0.55. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 earnings per share. Analysts expect that CVS Health Co. will post 6.27 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.32%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 47.33%.

Analyst Ratings Changes

Several research analysts have commented on the company. Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Mizuho dropped their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Truist Financial boosted their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research note on Friday, October 11th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and increased their price target for the company from $59.00 to $85.00 in a research note on Friday, October 4th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Nine investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $73.11.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.